SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-052024
Filing Date
2022-10-04
Accepted
2022-10-04 08:00:31
Documents
2
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4248
2 POA DOCUMENT poa.txt EX-24 3361
  Complete submission text file 0001209191-22-052024.txt   9250
Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TEMPEST THERAPEUTICS, INC. 7000 SHORELINE COURT, SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address
Trojanowski Justin (Reporting) CIK: 0001947673 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35890 | Film No.: 221289757